Oscar Total Hip Arthroplasty (CG070) Form


Total Hip Arthroplasty (Unilateral)

Notes: Please note that total hip arthroplasty for unilateral hip replacement may require prior failure of surgical interventions, post-traumatic injury, bone tumor, or dysplasia indications.

Indications

(857786) Does the patient have advanced joint disease with radiologic or arthroscopic findings of hip joint destruction, such as Kellgren-Lawrence Grade III or IV, Tönnis Classification Grade 3, symptomatic avascular necrosis with femoral head collapse, or symptomatic inflammatory joint disease with radiographic changes? 
(857787) Has the patient experienced severe pain persisting in the affected hip that interferes with functional or age-appropriate activities for at least 3 months despite treatment? 
(857788) Has the patient undergone a failed 3-month trial of conservative non-surgical treatment including physical therapy, medication, therapeutic injections (not within three months before surgery), and, if applicable, management documented for members with BMI over 40? 
(857789) If applicable, is there documentation showing FDA approval for the device, implant, or prosthesis to be inserted during surgery? 

Contraindications

(857790) Is there any contraindication such as active infection in the hip, allergy to components of the implant, generalized infection under medical management, or if the member has not reached skeletal maturity? 
YesNoN/A
YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

NA

Last Reviewed

NA

Original Document

  Reference



Total hip arthroplasty (THA) or total hip replacement is surgical reconstruction or replacement of the entire hip and composed of the femoral head (ball) and the acetabulum (socket). The components for a total hip arthroplasty implant are a separate femoral stem, femoral head (bearing surface), acetabular liner (bearing surface), and acetabular shell. There are many conditions that may deteriorate the hip joint that leads to pain and decreased mobility. A detailed musculoskeletal examination should be performed to assess hip anatomy, special leg tests, differential diagnosis, and pain patterns. This guideline does not address partial hip arthroplasty (hip hemiarthroplasty), hip arthroscopy, or hip resurfacing, please see MCG criteria. Definitions “Ambulatory”is a stay in a facility for up to 23 hours. “Avascular necrosis” is spontaneous osteonecrosis (bone death) when there is alteration of blood supply to the bone with unknown etiology. There are numerous causes for avascular necrosis, but in some cases the cause is unknown. 1 “Kellgren-Lawrence System” is a five-grade classification system describing radiographic findings for osteoarthritis (Table 1). Table 1. Kellgren-Lawrence System for classifying osteoarthritis Grade Radiographic Findings 0 I II III No radiographic features of osteoarthritis are present Doubtful joint space narrowing and possible osteophytic lipping Definite osteophytes and possible joint space narrowing Moderate multiple osteophytes, definite joint space narrowing, some sclerosis, and possible deformity of bone contour IV Large osteophytes, marked joint space narrowing, severe sclerosis, and definite deformity of bone contour “Osteoarthritis” (degenerative joint disease) is the most common form of arthritis and occurs when cartilage gradually wears down and affected bones no longer have the cushion of protective tissue. The primary symptoms are joint pain, stiffness and movement restriction. “Revision” of total hip replacement is when surgery is needed to replace or reconstruct prior hip replacement due to failure, infection, instability or other indications. “Rheumatoid arthritis” is an autoimmune disease causing chronic inflammation in joints and tissue. Over long periods of time, the inflammation can cause joint deformity, bone and cartilage erosion. “Tönnis Classification System” is a grading system with progressive degrees of degenerative changes in the hip (Table 2). Table 2. Tönnis Classification System for presence of osteoarthritis in the hips Grade 0 No signs of osteoarthritis Grade 1 -Slight narrowing of joint space; and -Slight lipping at joint margin; and -Slight sclerosis of the femoral head or acetabulum Grade 2 -Small cysts in the femoral head or acetabulum; and -Increasing narrowing of joint space; and -Moderate loss of femoral head sphericity 2 Grade 3 -Large cysts; and -Severe narrowing or obliteration of the joint space; and -Severe deformity of the femoral head; and -Avascular necrosis Clinical Indications General Clinical Indications (For partial hip arthroplasty, hip arthroscopy, or hip resurfacing, please see MCG criteria) Total hip arthroplasty for a unilateral hip is considered medically necessary when ONE of the following criteria is met: 1. The member has advanced joint disease as indicated by ALL of the following: a. Radiologic or arthroscopic findings of advanced hip joint destruction of ONE of the following: i. ii. iii. Kellgren Lawrence Grade III or IV radiographic findings (Table 1); or Tönnis Classification Grade 3 radiographic findings (Table 2); or Symptomatic avascular necrosis with the collapse of the femoral head with accompanying radiographic changes; or iv. Symptomatic inflammatory joint disease (arthropathy) affecting both the femoral head and acetabulum with joint space narrowing, bone-on-bone, with accompanying radiographic changes ; and b. Severe pain persisting in the affected hip that interferes with functional activity or age-appropriate activities for at least 3-months (e.g., ambulation, prolonged standing, ability to sleep); and c. There has been a failure to decrease pain or improve function after at least a 3-month trial of conservative treatment (non-surgical) which has included ALL of the following: i. Active and ongoing participation in a physical therapy (documentation), or a well documented home exercise program under the supervision of a physical therapist or physician, (e.g., lower extremity flexibility and strengthening program), activity modification, and/or weight loss program); and ii. Oral/topical medications (e.g., analgesics, NSAIDs, tumor necrosis factor inhibitors), unless poorly tolerated or contraindicated; and iii. Therapeutic injections to the hip and not within three months before the surgery date (unless contraindicated, examples include, but not limited to as bone-on-bone, osteolytic cysts, osteophytes, and sclerosis); and iv. For members with >40 BMI (Class III obesity), 6 months of non-surgical management have been documented; and d. If there is a separate request for the device, implant or prosthesis that will be inserted during surgery, it must be FDA approved (unless the member is enrolled in an approved clinical trial as defined by the plan benefit); and 3 e. If the member is a smoker or nicotine product user, the member has stopped using within 4 weeks of surgery or has been provided a well documented education plan on options to quit such as referral to a cessation program, pharmacologic, and over the counter treatments have been documented; and f. No contraindication present or the request is not considered Experimental or Investigational, or Not Medically Necessary based on the indications listed below; or 2. Failure of previous surgical interventions such as ONE of the following: a. Hip non-union or failure of previous hip fracture surgery; or b. Previous femoral or acetabular osteotomy; or c. Previous partial hip arthroplasty that needs conversion to total hip arthroplasty; or 3. Post-traumatic injury (e.g., fracture, infection) causing debilitating hip joint destruction affecting movement, causing pain and stiffness; or 4. Bone tumor or dysplasia involving the hip that requires excision. SimultaneousHipSurgery Total hip arthroplasty for simultaneous bilateral surgery is considered medically necessary if ALL of the following criteria are met: 1. Each hip meets medical necessity for criteria under General Clinical Indications; and 2. Meets the inpatient hospital Levels of Care criteria (see below). Removal or Revision of Total Hip Arthroplasty Removal(resectionwithsubsequentreimplantationatalatertimeorpermanentresectionarthroplasty withnoreimplantationplanned)orRevision(membersmayrequiremulti-stagedsurgeriestocomplete revisionovertime) The removal or revision of a total hip prosthesis is considered medically necessary when ALL of the following criteria are met: 1. No current or ongoing hip infection (e.g., supporting labs and cultures, no longer on antibiotics, assessment by treating surgeon); and 2. One of the following: a. Bearing surface wear leading to symptomatic synovitis, destruction of local bone, or soft tissue reaction;or b. Infected hip prosthesis;or c. Periprosthetic infection;or d. Prosthesis/hardware failure, damage or fracture;or e. Loosening of prosthesis, implant or components that is confirmed by imaging;or f. Periprosthetic Hip fracture;or g. Recurrent instability or dislocation of the hip prosthetic;or h. The member has functional disability AND persistent pain for more than 6 months;or i. Significant leg discrepancy post THA; or 3. Additional staged surgery is needed as part of a multispecialty approach to any one of the conditions listed above. This could include, but is not limited to, the replacement of 4 impregnated antibiotic spacers, additional joint washouts, and the removal or replacement of hardware. Levels of Care AmbulatorySurgicalCenter,OutpatientHospital The following indications are appropriate for ambulatory surgical centers and outpatient hospital level of care: ● Unilateral THA ● Select ambulatory centers with capability to perform bilateral THA and each hip must meet medical necessity ● Staged THA on both hips (request for each hip still needs to meet medical necessity and staggered typically between 30-90 days following the first total hip joint replacement). ● An additional day as an ambulatory or observation level of care might be needed for a safe transition to oral pain medication. InpatientHospital Inpatient hospital level of care simultaneous bilateral total hip arthroplasty may be considered medically necessary if an ambulatory or outpatient hospital is unable to monitor the member’s needs. Furthermore, each hip must meet medical necessity. The member may also meet inpatient hospital level of care for unilateral or bilateral hip replacement if ONE of the following are met: ● Non-elective surgery for unilateral or bilateral; or ● For members requesting unilateral or bilateral revision procedures that require an extended stay outside of the ambulatory or outpatient hospital timeframe, or are unable to be discharged and expected to be admitted/transferred to acute or subacute rehab facility (the member must also meet Oscar’s utilization review criteria for the rehabilitation facility); or ● The member requires more prolonged postoperative treatment or management for unilateral or bilateral due to comorbidities which may include ANY of the following: ○ need for parenteral bridging anticoagulation ○ NYHA class III or IV heart failure ○ pulmonary fibrosis ○ pulmonary hypertension ○ history of thromboembolism ○ extensive edema ○ chronic systemic corticosteroid use ○ severely reduced renal function ○ Poorly controlled type 1 diabetes ○ recent history of falls ○ Significant dementia 5 ○ BMI > 40 ○ Age > 70 and an additional comorbidity as listed in this section ○ Significant movement abnormalities (eg, stroke, Parkinson disease, dependent functional status); or ● For a member to meet inpatient level of care for pain management after THA surgery, the member must meet the criteria in MCG Pain Management GRG (PG-PM) criteria for unilateral or bilateral; or ● An inpatient admission for a unilateral or bilateral request may be considered medically necessary when the member meets MCG Ambulatory Surgery Exception Criteria (CG-AEC). ExtensionRequests The Plan considers extension requests for inpatient level of care medically necessary when the member continues to meet extension criteria in MCG Hip Arthroplasty for milestones of recovery, clinical status is improving during IP stay, and is not ready to be transitioned to an alternative or lower level of care. Extension requests should be based on medical records of progress. Experimental or Investigational / Not Medically Necessary The Plan considers the following conditions as contraindications: ● Active infection in the hip, unless surgery is for revision for THA ● Active wound or skin infection at the planned hip joint for surgery ● Allergy to components of the implant ● Generalized infection, active illness under medical managementThe member has not reached skeletal maturity The following indications are considered not medically necessary: ● Charcot joint ● Customized total or partial hip implant ● Progressive neurologic disease affecting lower extremities or significant muscular atrophy of the hip or leg musculature that would compromise stability ● Severe immunocompromised system ● Vascular insufficiency that would compromise recovery ● Any disease or process that rapidly destroys bone The following indications are considered experimental/investigational/unproven: ● Computer-Assisted Total Hip Arthroplasty (CA-THA) for surgical navigation uses anatomical landmarks to collect morphologic information to provide intraoperative feedback regarding component positioning and alignment (e.g. OrthoGrid Hip AI). 6